Trial intelligence / Profile preview

Amantadine for Functional Recovery in Severe Traumatic Brain Injury

NCT00970944Phase 3Completed

Sponsor
JFK University Medical Center
Start
Feb 2003
Primary completion
Mar 2010
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of amantadine in traumatic brain injury (TBI), sponsored by JFK University Medical Center. Started Feb 2003; status: completed.

02

Drugs

amantadine
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT00970944.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00970944.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call